Combating Illicit Xylazine Act

Plain-English Summary: Combating Illicit Xylazine Act

This bill takes aim at xylazine, a powerful animal sedative that has increasingly appeared in the illegal drug supply, often mixed with fentanyl and other substances. Xylazine is not currently classified as a controlled substance under federal law, which limits how law enforcement and public health officials can respond to its spread. This legislation would change that by placing xylazine under stricter federal regulation, making it harder to obtain and distribute illegally.

The bill primarily affects people involved in the manufacture, distribution, or possession of xylazine outside of its legitimate veterinary uses. Veterinarians and licensed animal care professionals who use xylazine legally in their work would still be able to access it, but the bill would create new legal consequences for those trafficking or misusing the drug. Law enforcement agencies would gain additional tools to prosecute illegal xylazine distribution.

The bill also has implications for people struggling with substance use disorders, as xylazine has been linked to severe skin wounds and other serious health complications that standard overdose treatments like naloxone cannot fully address. By targeting the illegal supply of xylazine, supporters of the legislation hope to reduce the harm it causes in communities already dealing with the opioid crisis. The bill has been referred to two House committees — Energy and Commerce, and the Judiciary — where members will review it before deciding whether to advance it further.